Name: TriSalus Life Sciences, Inc. (TLSI) Balance Sheet
Creator: FinSpry

TriSalus Life Sciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for TriSalus Life Sciences, Inc. (TLSI) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	8.53	11.78	9.41	30.30	4.49
Cash & Short-Term Investments	8.53	11.78	9.41	30.30	4.49
Accounts Receivable	5.09	3.55	1.56	1.36	0.62
Inventory	4.05	2.55	1.47	1.29	0.57
Other Current Assets	3.01	2.99	4.77	2.18	0.00
Total Current Assets	20.67	20.86	17.21	35.13	6.08
Non-Current Assets
Property, Plant & Equipment (Net)	2.88	3.27	3.61	1.80	1.26
Long-Term Investments	0.35	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	0.80	0.79	0.74
Other Non-Current Assets	0.42	0.47	0.37	0.12	0.05
Total Non-Current Assets	3.30	3.74	4.78	2.71	0.00
Total Assets	23.97	24.60	22.00	37.84	8.13
Current Liabilities
Accounts Payable	2.27	3.39	4.95	1.30	0.61
Short-Term Debt	0.43	0.00	0.00	0.00	42.18
Current Portion of Long-Term Debt	0.00	0.00	0.00	0.00	42.18
Accrued Liabilities	4.87	10.53	6.38	4.97	6.73
Other Current Liabilities	0.38	0.39	20.66	0.10	5.22
Total Current Liabilities	10.23	14.69	32.36	6.37	54.75
Non-Current Liabilities
Long-Term Debt	22.08	1.24	1.59	0.00	0.00
Other Non-Current Liabilities	16.22	35.73	0.37	0.56	3.54
Total Non-Current Liabilities	39.64	36.98	165.97	161.07	0.00
Total Liabilities	49.87	51.66	34.32	6.93	58.29
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.01	0.01
Retained Earnings	-279.55	-249.50	-186.36	-136.34	-107.50
Additional Paid-in Capital	253.65	222.44	10.03	6.73	0.00
Shares Outstanding	31.28	26.41	26.32	26.32	0.00
Total Stockholders' Equity	-25.89	-27.07	-12.32	30.90	-50.16
Total Liabilities & Equity	23.97	24.60	22.00	37.84	0.00